Denali Therapeutics Inc. DNLI Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s change in other assets?
- Denali Therapeutics Inc. (DNLI) reported change in other assets of $700K in Q1 2026.
- How has Denali Therapeutics Inc.'s change in other assets changed year-over-year?
- Denali Therapeutics Inc.'s change in other assets decreased by 25.8% year-over-year, from $943K to $700K.
- What is the long-term trend for Denali Therapeutics Inc.'s change in other assets?
- Over 3 years (2021 to 2024), Denali Therapeutics Inc.'s change in other assets has grown at a -63.9% compound annual growth rate (CAGR), from $12.87M to -$603K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.